Drug Type Small molecule drug |
Synonyms DM 3100, DM3100 |
Target |
Action modulators |
Mechanism TAS1R3 modulators(taste 1 receptor member 3 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | South Korea | 12 Jul 2021 |